Current Vascular Pharmacology
Title: Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?]
Volume: 5 Issue: 3
Author(s): Anna I. Kakafika, Dimitri P. Mikhailidis, Anthony S. Wierzbicki, Asterios Karagiannis and Vasilios G. Athyros
Affiliation:
Keywords: Percutaneous coronary intervention, stents, medical treatment, treatment cost
Export Options
About this article
Cite this article as:
Anna I. Kakafika , Dimitri P. Mikhailidis , Anthony S. Wierzbicki , Asterios Karagiannis and Vasilios G. Athyros , Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?], Current Vascular Pharmacology 2007; 5 (3) . https://dx.doi.org/10.2174/157016107781024145
DOI https://dx.doi.org/10.2174/157016107781024145 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Acute Coronary Syndromes: A Role of Immune System
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Ageing Mechanisms and Associated Lipid Changes
Current Vascular Pharmacology The Effect of Local Alcohol Delivery in Reducing Intimal Hyperplasia Induced by Vascular Injury and the Clinical Implications
Vascular Disease Prevention (Discontinued) A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence
Current Drug Targets - Cardiovascular & Hematological Disorders [11C]Meta-Hydroxyephedrine PET/CT
Current Radiopharmaceuticals New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury
Current Drug Targets Progress and Prospects of Stem Cells in Treatment of Drug Resistant Tuberculosis
Current Respiratory Medicine Reviews COVID-19 Severity: Lung-Heart Interplay
Current Cardiology Reviews Is It Possible to Apply Secondary Stroke Prevention Guidelines to Very Old Populations?
Cardiovascular & Hematological Disorders-Drug Targets Structure of Atherosclerotic Plaques in Different Vascular Territories: Clinical Relevance
Current Vascular Pharmacology Repositioning of HIV Aspartyl Peptidase Inhibitors for Combating the Neglected Human Pathogen Trypanosoma cruzi
Current Medicinal Chemistry Walnut Extract Inhibits the Fibrillization of Amyloid Beta-Protein, and also Defibrillizes its Preformed Fibrils
Current Alzheimer Research Nitric Oxide-Mediated Endothelial Dysfunction - Is there Need to Treat?
Current Vascular Pharmacology Syntheses and Antitumor Properties of Furoxan Derivatives
Current Organic Chemistry Comparative Study of Non-High Density Lipoproteins Cholesterol Level and Lipid Profile in Pre-Diabetic and Diabetic Patients
CNS & Neurological Disorders - Drug Targets ACE2 as a Key Target for Treatment of COVID-19 Related Cardiovascular Diseases: Current Progress and Prospect
Current Drug Targets Cardiovascular Molecular Imaging: New Methodological Strategies
Current Pharmaceutical Design Antimutagenic Activity of Lutein –An Oxycarotenoid Present in the Macula and its Inhibition of Cytochrome P 450 Enzymes in vitro
Drug Metabolism Letters Memory Impairment is Associated with Serum Methylarginines in Older Adults
Current Alzheimer Research Psychoemotional Background of Temporomandibular Joint Dysfunction and Possible Drug Therapy
Letters in Drug Design & Discovery